Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 28 02:09PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.16 Insider Own23.74% Shs Outstand42.41M Perf Week2.50%
Market Cap20.37M Forward P/E- EPS next Y-1.15 Insider Trans0.00% Shs Float32.35M Perf Month-10.91%
Income-56.85M PEG- EPS next Q-0.22 Inst Own50.12% Short Float / Ratio2.06% / 2.91 Perf Quarter-37.64%
Sales0.00M P/S- EPS this Y65.34% Inst Trans-3.72% Short Interest0.67M Perf Half Y-88.96%
Book/sh1.47 P/B0.33 EPS next Y19.22% ROA-53.76% Target Price4.83 Perf Year-52.46%
Cash/sh2.24 P/C0.21 EPS next 5Y- ROE-87.77% 52W Range0.36 - 5.89 Perf YTD-49.45%
Dividend- P/FCF- EPS past 5Y- ROI-61.54% 52W High-91.85% Beta0.45
Dividend %- Quick Ratio12.99 Sales past 5Y0.00% Gross Margin- 52W Low32.29% ATR0.06
Employees33 Current Ratio12.99 Sales Q/Q- Oper. Margin0.00% RSI (14)46.38 Volatility10.45% 14.02%
OptionableNo Debt/Eq0.48 EPS Q/Q84.96% Profit Margin- Rel Volume0.07 Prev Close0.48
ShortableYes LT Debt/Eq0.48 EarningsNov 02 BMO Payout- Avg Volume228.35K Price0.48
Recom1.00 SMA204.53% SMA50-16.03% SMA200-68.15% Volume12,300 Change0.67%
Date Action Analyst Rating Change Price Target Change
May-30-23Upgrade SVB Securities Market Perform → Outperform $5 → $8
Dec-23-21Initiated H.C. Wainwright Buy $12
Nov-22-23 07:30AM
Nov-02-23 09:40AM
Sep-05-23 07:30AM
Aug-16-23 07:30AM
07:30AM Loading…
Aug-03-23 07:30AM
Jul-13-23 08:00AM
Jun-08-23 10:41PM
Jun-03-23 09:00AM
May-19-23 06:54AM
May-15-23 07:30AM
Apr-26-23 04:05PM
Apr-17-23 10:15AM
Mar-23-23 09:40AM
04:30PM Loading…
Mar-14-23 04:30PM
Mar-09-23 07:30AM
Mar-01-23 07:00AM
Feb-08-23 07:00AM
Jan-09-23 07:30AM
Jan-06-23 08:15AM
Nov-30-22 07:30AM
Nov-03-22 07:30AM
Aug-12-22 09:30AM
Aug-04-22 07:30AM
Aug-03-22 08:00AM
Jul-28-22 08:50AM
Jul-14-22 08:45AM
Jun-01-22 07:30AM
05:05PM Loading…
May-26-22 05:05PM
May-25-22 07:30AM
May-05-22 07:30AM
Apr-27-22 10:05AM
Mar-24-22 01:12PM
Mar-14-22 07:00AM
Mar-03-22 07:30AM
Mar-01-22 07:00AM
Jan-10-22 07:00AM
Jan-06-22 08:00AM
Jan-05-22 08:00AM
Dec-16-21 09:14AM
Nov-18-21 08:00AM
Nov-12-21 07:30AM
Oct-20-21 07:00AM
Oct-14-21 07:00AM
Sep-25-21 09:52AM
Sep-07-21 07:00AM
Aug-12-21 04:05PM
Aug-04-21 07:00AM
Jun-24-21 08:44PM
Elevation Oncology, Inc. is a precision oncology company. It focuses on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm's program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.